1. Watch our video:
See how the KPMG Health Authority Inquiry (HAI) accelerator can help create greater efficiency, visibility, and control in the HAI process while reducing risk and improving regulatory strategy.
Coming soon!
KPMG Health Authority Inquiry (HAI)
Gain greater efficiency, visibility, and control in the HAI process
KPMG Health Authority Inquiry (HAI) can help
Life sciences companies receive thousands of inquiries per year from healthcare authorities. Responding requires enormous financial and labor resources, and the process is burdened with inefficiencies. Manual input can introduce the possibilities of errors and redundancies.
The KPMG Health Authority Inquiry (HAI) accelerator is designed to streamline the process. Assisted by AI, HAI automates the inquiry intake and helps classify and assign questions to the right subject matter experts. Insights from similar past questions and responses are easily available to aid in response generation.
HAI also offers translation capabilities so, no matter what the language of the inquiry, they can be responded to in a timely manner. Through intuitive and easy-to-use dashboards, users now can simplify and speed up the inquiry process, save time, reduce potential errors, and gain greater control.
Potential benefits of KPMG Health Authority Inquiry (HAI)
KPMG HAI allows organizations to build a repository of searchable questions and their responses that users can leverage for future inquiries. In doing so:
1
Responses become more consistent and there are fewer knowledge gaps or errors.
2
Efficiency gains give time back to your employees.
3
Workflows between systems are improved.
4
Health Authority-mandated timeframes are met.
5
Complex manual activities are automated.
6
Global queries receive timely response, no matter what language.
7
Reports are tailored to give you greater visibility into cycle time metrics, submission performance, and AI performance
KPMG Health Authority Inquiry (HAI) is fully automated for speed and efficiency
HAI requests are automated. When a health authority inquiry arrives, AI scans the request for relevant information like due dates, which health authority sent it, which application or product it references, and more. The tool then creates a structured record and assigns it to the appropriate Inquiry Owner.
From there, the Inquiry Owner confirms intake and assigns it to a Response SME who looks up similar questions, drafts, and finalizes a response, which KPMG HAI stores and marks the inquiry closed.
Streamline your approach to the Health Authority Inquiries process
2. Read about the benefits:
At KPMG, we bring together our Technology, Risk, and Compliance teams to help life sciences organizations transform how they manage Health Authority inquiries. With our Health Authority Inquiries (HAI) accelerator, we automate the intake of regulatory correspondence, streamline workflows, support consistent response drafting using client-approved templates, and build a smart, searchable repository of past inquiries and responses to improve future decision-making. Our deep industry expertise and proven transformation methodologies ensure that clients not only implement the right tools but also evolve their processes to reduce manual effort, minimize regulatory risk, and enhance response quality across their global operations.
3. See the advanced outcomes:
Faced with limited visibility and inefficient tracking, a global pharmaceutical company struggled to manage Health Authority Inquiries (HAIs), making regulatory compliance reporting difficult. KPMG implemented an automated intake solution that streamlined workflows, enabled automated responses, and maintained a comprehensive historical record for future reference.
Within just three months of go-live, the solution successfully processed over 3,500 HAIs and supported more than 1,000 regulatory end users across the globe—transforming compliance operations with speed, scale, and confidence.
4. Request a demo:
Start the conversation today!
Meet our team
Sean Berquist
Advisory Managing Director, KPMG LLP
Brian Williams
Managing Director, Life Sciences Advisory, KPMG US
Sean Berquist
Advisory Managing Director, KPMG LLP
Brian Williams
Managing Director, Life Sciences Advisory, KPMG US